Oragenics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Janet Huffman, with a market cap of $2.7M.
Common questions about Oragenics
Oragenics is scheduled to report earnings for Q1 2026 on May 8, 2026.
Oragenics has approximately 5 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.